Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06985953 · ClinicalTrials.gov registry record · NA

Evaluating the Communication Between Patients and Providers in Cancer Clinics

A NA study of Cancer, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
3
Study locations

NCT06985953 is a NA study of Cancer that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 30 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06985953, a NA study of Cancer, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
3
Study locations

Study Summary

This clinical trial seeks to understand patients' experiences with the healthcare team and the quality of communication between patients and doctors in cancer clinics. The main question it aims to answer is: * Does TrialTalk™ improve communication between providers and patients? Participants will complete questionnaires before and after their standard of care clinic visit.

Conditions Studied

Interventions

  • OTHER TrialTalk™

Study Locations (3)

Illinois

  • Northwestern Memorial Hospital - Chicago

South Carolina

  • Medical University of South Carolina - Charleston

Wisconsin

  • University of Wisconsin - Madison - Madison

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-03
Est. Completion 2027-02
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT06985953

The ClinicalTrials.gov registry entry for NCT06985953 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which TrialTalk™ is the first listed.

NCT06985953 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Illinois, South Carolina, Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06985953 about?

NCT06985953 is a clinical study titled "Evaluating the Communication Between Patients and Providers in Cancer Clinics". This clinical trial seeks to understand patients' experiences with the healthcare team and the quality of communication between patients and doctors in cancer clinics. The main question it aims to answer is: * Does TrialTalk™ improve communication between providers and patients? Participants will ...

What is the current status of trial NCT06985953?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-03. Estimated completion is 2027-02.

What conditions does trial NCT06985953 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT06985953?

The interventions under investigation include: TrialTalk™ (OTHER).

Who is sponsoring clinical trial NCT06985953?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06985953 being conducted?

This trial has 3 study locations across Illinois, South Carolina, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.